| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | DEXCOM | 362,733 | 29,708,000 | 1.27% | ||
| 52 | UNITED THERAPEUTICS | 195,280 | 30,583,000 | 1.30% | ||
| 53 | ALDER BIOPHARMACEUTICALS INC | 934,951 | 30,881,000 | 1.32% | ||
| 54 | MYLAN N V | 601,910 | 32,545,000 | 1.39% | ||
| 55 | INTERCEPT PHARMACEUTICAL | 220,047 | 32,864,000 | 1.40% | ||
| 56 | SHIRE PLC | 164,674 | 33,758,000 | 1.44% | ||
| 57 | HALOZYME THERAPEUTICS INC | 2,075,796 | 35,974,000 | 1.53% | ||
| 58 | TEVA PHARMACEUTICAL INDS LTD | 605,922 | 39,773,000 | 1.70% | ||
| 59 | MEDTRONIC PLC | 543,792 | 41,828,000 | 1.78% | ||
| 60 | LILLY ELI & CO | 599,245 | 50,492,000 | 2.15% | ||
| 61 | PTC THERAPEUTICS INC | 1,586,258 | 51,395,000 | 2.19% | ||
| 62 | ACCELERON PHARMA | 1,121,264 | 54,673,000 | 2.33% | ||
| 63 | SEATTLE GENETICS INC | 1,275,775 | 57,257,000 | 2.44% | ||
| 64 | MERCK & CO INC | 1,121,925 | 59,260,000 | 2.53% | ||
| 65 | AMICUS THERAPEUTICS INC | 7,973,436 | 77,342,000 | 3.30% | ||
| 66 | AMGEN INC | 504,597 | 81,911,000 | 3.49% | ||
| 67 | THERMO FISHER SCIENTIFIC INC | 606,936 | 86,094,000 | 3.67% | ||
| 68 | VERTEX PHARMACEUT | 688,200 | 86,596,000 | 3.69% | ||
| 69 | BIOGEN INC | 290,889 | 89,114,000 | 3.80% | ||
| 70 | INCYTE | 1,127,423 | 122,269,000 | 5.21% | ||
| 71 | REGENERON PHARMACEUTICALS | 236,300 | 128,280,000 | 5.47% | ||
| 72 | CELGENE CORP | 1,177,058 | 140,964,000 | 6.01% | ||
| 73 | BIOMARIN | 1,359,922 | 142,465,000 | 6.07% | ||
| 74 | ALEXION PHARMACEUTIC | 758,180 | 144,623,000 | 6.17% | ||
| 75 | GILEAD SCIENCES INC | 1,782,298 | 180,351,000 | 7.69% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001104659-16-096363, filed 2016.02.12).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
